Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
NVAXNovavax(NVAX) Zacks Investment Research·2024-05-10 20:06

Novavax (NVAX) came out with a quarterly loss of 1.05pershareversustheZacksConsensusEstimateofalossof1.05 per share versus the Zacks Consensus Estimate of a loss of 1.04. This compares to loss of 3.41pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−0.963.41 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -0.96%. A quarter ago, it was expected that this vaccine maker would post a loss of 0.49 per share when it actually produced a loss of $1.44, delivering a surprise of -193.88%. Over the last four quarters, the company has surpas ...